Vessel Closure

Abbott is committed to providing hemostasis management solutions to help patients and hospitals thrive. Time management, patient and staff flow, hospital costs, and throughput can all impact overall hospital efficiency.

Our hemostasis management portfolio aims to drive hospital efficiency through:

• Early ambulation 7,8,9
• Reducing patient length of stay 5,8,9
• Lowering access site-related complications 5,8,9
• Improving patient outcomes 6,7

• Optimizing nursing time 8,9
• Driving overall hospital efficiency 8,9
• Improving patient flow 8,9

Vascular Closure Systems

Perclose™ ProStyle™ Suture-Mediated Closure and Repair (SMCR) System 10

• The Perclose™ ProStyle™ Suture-Mediated Closure and Repair (SMCR) System is the next generation design evolution of the proven and trusted Perclose ProGlide™ SMC System.
• Similar to the Perclose ProGlide™ device, each Perclose™ ProStyle™ device delivers the same secure, non-masking percutaneous suture to the access site that promotes primary intention healing 1 and has no reaccess restrictions. 10
• The updated Perclose™ ProStyle™ SMCR System has been designed with features such as high-tensile strength needles for more reliability in complex and challenging anatomies, additional visual cues for a more intuitive deployment experience, and the addition of our popular Perclose™ Snared Knot Pusher which offers a more tactile and tapered knot advancement.

Perclose ProGlide™ Suture-Mediated Closure (SMC) System 11

• Perclose ProGlide™ SMC System delivers a secure, non-masking percutaneous suture to the access site that promotes primary intention healing 1 and has no re-access restrictions. 11
• This system has the broadest arterial and venous indication*; it can be utilized for 5-21F 2 (Max. 26F OD 3 ) arterial sheaths and 5-24F 2 (Max. 29F OD 3 ) venous sheaths.

StarClose SE™ Vascular Closure System (VCS) 12

• StarClose SE™ Vascular Closure System is indicated for 5-6F arterial access procedures and provides safe 4 , easy and extravascular percutaneous closure for diagnostic or interventional procedures.

Prostar XL™ Percutaneous Vascular Surgical System (PVSS) 13

• Prostar XL™ Percutaneous Vascular Surgical System is indicated for 8.5-10F arterial access sites and uses two braided sutures to provide a secure closure.

Compression Assist Devices

FemoStop™ Gold Compression Assist Device 14

The FemoStop™ Compression Assist Device uses hands-free compression of the femoral artery or vein to offer precise hemostasis management and patient comfort.

• The adjustable belt fits securely so that small patient movements may not cause the device to slip and patients can rest comfortably
• Hands-free compression
  • Allows multiple patients to be monitored at one time, increasing staff efficiency
  • Minimizes staff exposure to blood and reduces neck, arm and wrist fatigue

  

  

  Manuals & Technical Resources

  

  

  References

  *As compared to Angio-Seal ‡ , ExoSeal ‡ , Celt ACD, MANTA ‡ , Mynx ‡ , Vascade ‡ ,
  Data on file at Abbott.

  1. Primary intention healing occurs where vessel wall edges are brought together, adjacent to each other. This can be achieved with sutures and other methods. Advances in Skin & Wound Care: Healing by Intention. Salcido, Richard. 2017.
  2. For arterial sheath sizes greater than 8F, at least two devices and the pre-close technique are required. For venous sheath sizes greater than 14F, at least two devices and the pre-close technique are required.
  3. Max. OD 26F = 0.340 inches = 8.62 mm; Max. OD 29F = 0.378 inches = 9.59 mm. Data on file at Abbott.
  4. Burke et al. StarClose Vascular Closure System (VCS) is Safe and Effective in Patients Who Ambulate Early Following Successful Femoral Artery Access Closure - Results from the RISE Clinical Trial. CCI 2012, 80:45-52.
  5. Fabbricatore D et al. (2023) Ambulatory PV isolation workflow using suture-mediated vascular closure devices: a prospective observational cohort study. (PRO-PVI Study). Europace. 25(4):1361-1368
  6. Schneider, Darren B; Krajcer, Zvonimir; et al. Perclose ProGlide Versus Surgical Closure Outcomes - Real World Evidence. LINC 2018.
  7. Kar, Saibal; Hermiller, James; et al. The Use of the Perclose ProGlide Suture Mediated Closure (SMC) Device for Venous Access-Site Closure up to 24F Sheaths. CRT 2018.
  8. Verma S., et al. Feasibility and Safety of Same Day Discharge for Patients Undergoing Atrial Fibrillation (AF) Ablation in a Community Hospital Setting. HRS 2020 Poster.
  9. Verma S. Same-Day Discharge for AF Ablation: What Have We Learned - EP Lab Digest - August 2020.
  10. Perclose™ ProStyle™ SMCR System - Instructions for Use (IFU). Refer to IFU for additional information.
  11. Perclose ProGlide™ SMC System - Instructions for Use (IFU). Refer to IFU for additional information.
  12. StarClose SE™ VCS System - Instructions for Use (IFU). Refer to IFU for additional information.
  13. Prostar XL™ PVS System - Instructions for Use (IFU). Refer to IFU for additional information.
  14. FemoStop™ II Plus Femoral Compression System - Instructions for Use (IFU). Refer to IFU for additional information.

  Important Safety Information

  Perclose™ ProStyle™ Suture-Mediated Closure and Repair (SMCR) System

  Indications:

  The Perclose™ ProStyle™ Suture-Mediated Closure and Repair System is indicated for the percutaneous delivery of suture for closing the common femoral artery and vein access sites of patients who have undergone diagnostic or interventional catheterization procedures.

  The Perclose™ ProStyle™ SMCR System is indicated for closing the common femoral vein in single or multiple access sites per limb.

  The Perclose™ ProStyle™ SMCR System is used without or, if required, with adjunctive manual compression.

  For access sites in the common femoral artery using 5F to 21F sheaths. For arterial sheath sizes greater than 8F, at least two devices and the pre-close technique are required.

  For access sites in the common femoral vein using 5F to 24F sheaths. For venous sheath sizes greater than 14F, at least two devices and the pre-close technique are required.

  Caution:

  Federal law restricts this medical device to sale by or on the order of a physician (or allied healthcare professionals, authorized by, or under the direction of, such physicians) who is trained in diagnostic and / or interventional catheterization procedures and who has been trained by an authorized representative of Abbott.

  Prior to use, the operator must review the Instructions for Use and be familiar with the deployment techniques associated with the use of this device.

  During closure of access sites using a procedural sheath greater than 8F, it is recommended that a vascular surgeon or a surgeon with vascular training be available in case surgical conversion to control bleeding and to repair the vessel is needed.

  Contraindications:

  There are no known contraindications to the use of this device.

  Warnings :

  Do not use the Perclose™ ProStyle™ SMCR System if the packaging or sterile barrier has been previously opened or damaged or if the components appear to be damaged or defective.

  DO NOT RESTERILIZE OR REUSE. The Perclose™ ProStyle™ SMCR System is intended for single use only.

  Do not use the Perclose™ ProStyle™ SMCR System if the sterile field has been broken where bacterial contamination of the sheath or surrounding tissues may have occurred, since such a broken sterile field may result in infection.

  Do not use the Perclose™ ProStyle™ SMCR System if the puncture site is located above the most inferior border of the inferior epigastric artery (IEA) and / or above the inguinal ligament based upon bony landmarks, since such a puncture site may result in a retroperitoneal hematoma. Perform a femoral angiogram to verify the location of the puncture site. Note: This may require both a right anterior oblique (RAO) and left anterior oblique (LAO) angiogram to adequately visualize where the sheath enters the femoral vessel.

  Do not use the Perclose™ ProStyle™ SMCR System in arterial or venous access if the puncture is through the posterior wall or if there are multiple punctures in the same access site, since such punctures may result in a hematoma or retroperitoneal bleed.

  Do not use the Perclose™ ProStyle™ SMCR System if the puncture site is located in the superficial femoral artery or the profunda femoris artery, or the bifurcation of these vessels, since such puncture sites may result in a pseudoaneurysm, intimal dissection, or an acute vessel closure (thrombosis of small artery lumen). Perform a femoral angiogram to verify the location of the puncture site. Note: This may require both a right anterior oblique (RAO) and left anterior oblique (LAO) angiogram to adequately visualize where the sheath enters the femoral vessel.

  
  Precautions :

  1. Prior to use, inspect the Perclose™ ProStyle™ SMCR System to ensure that the sterile packaging has not been damaged during shipment. Examine all components prior to use to verify proper function. Exercise care during device handling to reduce the possibility of accidental device breakage.
  2. As with all catheter-based procedures, infection is a possibility. Observe sterile technique at all times when using the Perclose™ ProStyle™ SMCR System. Employ appropriate groin management, as per hospital protocol, post-procedure, and post-hospital discharge to prevent infection.
  3. Use a single wall puncture technique. Do not puncture the posterior wall of the vessel in arterial and venous access.
  4. Do not deploy the Perclose™ ProStyle™ Device at an elevated angle against resistance as this may cause a cuff miss or device breakage.
  5. There are no reaccess restrictions if previous arteriotomy / venotomy repairs were achieved with Abbott Medical SMC or SMCR systems.
  6. If significant blood flow is present around the Perclose™ ProStyle™ Device, do not deploy needles. Remove the device over a 0.038" (0.97 mm) (or smaller) guide wire and insert an appropriately sized sheath.
  7. Prior to depressing the plunger to advance the needles, stabilize the device by the body to ensure the foot is apposed to the vessel wall and the device does not twist during deployment. Twisting (torquing) of the device could lead to needle deflection resulting in a cuff miss. Do not use excessive force or repeatedly depress the plunger. Excessive force on the plunger during deployment could potentially cause breakage of the device, which may necessitate intervention and / or surgical removal of the device and vessel repair.
  8. Do not apply excessive force to the lever when opening the foot and returning the foot to its original position down to the body of the device. Do not attempt to remove the device without closing the lever. Excessive force on the lever or attempting to remove the device without closing the lever could cause breakage of the device and / or lead to vessel trauma, which may necessitate intervention and / or surgical removal of the device and vessel repair.
  9. Do not advance or withdraw the Perclose™ ProStyle™ Device against resistance until the cause of that resistance has been determined. Excessive force used to advance or torque the Perclose™ ProStyle™ Device should be avoided, as this may lead to significant vessel damage and / or breakage of the device, which may necessitate intervention and / or surgical removal of the device and vessel repair.
  10. If excessive resistance in advancing the Perclose™ ProStyle™ Device is encountered, withdraw the device over a 0.038" (0.97 mm) (or smaller) guide wire and reinsert the introducer sheath or use manual compression.
  11. Remove the Perclose™ ProStyle™ sheath before tightening the suture. Failure to remove the sheath prior to tightening the suture may result in detachment of the tip of the sheath.
  12. Care should be taken to avoid damage to the suture from handling. Avoid crushing damage due to application of surgical instruments such as clamps, forceps or needle holders.
  13. For catheterization procedures using a 5F – 8F procedural sheath, use manual compression in the event that bleeding from the femoral access site persists after the use of the Perclose™ ProStyle™ SMCR System to obtain hemostasis.
  14. For catheterization procedures using a procedural sheath > 8F, use manual compression, compression assisted devices, surgical repair, and / or other appropriate treatment methods in the event that bleeding from the femoral access site persists after the use of the Perclose™ ProStyle™ SMCR System to obtain hemostasis.
  15. For catheterization procedures using a procedural sheath > 8F, where the operating physician is not a vascular surgeon, it is recommended that a vascular surgeon or a surgeon with vascular training be available during the procedure to perform any necessary vascular surgical intervention.
  16. If the Perclose™ ProStyle™ Device is used to close and repair multiple access sites in the same vessel, space the access sites apart adequately to minimize sheath-device interference.

  Potential Adverse Events :

  Potential adverse events associated with use of vessel closure devices may include, but are not limited to, the following:

  • Allergic reaction or hypersensitivity to device components
  • Vascular access complications which may require transfusion or vessel repair, including:
    • Anemia
    • Aneurysm
    • Arteriovenous fistula
    • Bleeding / hemorrhage / re-bleeding
    • Bruising
    • Hematoma
    • Embolism
    • Inflammation
    • Intimal tear / dissection
    • Perforation
    • Pseudoaneurysm
    • Retroperitoneal hematoma / bleeding
    • Scar formation
    • Wound dehiscence
    • Atrial arrhythmias
    • Ventricular arrhythmias
    • Arterial / venous stenosis
    • Arterial / venous occlusion
    • Arteriovenous fistula
    • Intimal tear / dissection
    • Ischemia distal to closure site
    • Nerve injury
    • Numbness
    • Thrombus formation
    • Vascular injury
    • Hypotension / hypertension
    • Vasovagal episode

    Perclose ProGlide™ Suture-Mediated Closure (SMC) System

    Indications :

    The Perclose ProGlide™ Suture-Mediated Closure System is indicated for the percutaneous delivery of suture for closing the common femoral artery and vein access site of patients who have undergone diagnostic or interventional catheterization procedures.

    The Perclose ProGlide™ SMC System is indicated for closing the common femoral vein in single or multiple access sites per limb.

    The Perclose ProGlide™ SMC System is used without or, if required, with adjunctive manual compression.

    For access sites in the common femoral artery using 5F to 21F sheaths. For arterial sheath sizes greater than 8F, at least two devices and the pre-close technique are required.

    For access sites in the common femoral vein using 5F to 24F sheaths. For venous sheath sizes greater than 14F, at least two devices and the pre-close technique are required.

    Caution :

    Federal law restricts this medical device to sale by or on the order of a physician (or allied healthcare professionals, authorized by, or under the direction of, such physicians) who is trained in diagnostic and / or interventional catheterization procedures and who has been trained by an authorized representative of Abbott.

    Prior to use, the operator must review the Instructions for Use and be familiar with the deployment techniques associated with the use of this device.

    During closure of access sites using a procedural sheath greater than 8F, it is recommended that a vascular surgeon or a surgeon with vascular training be available in case surgical conversion to control bleeding and to repair the vessel is needed.

    Contraindications :

    There are no known contraindications to the use of this device.
    

    Warnings :

    Do not use the Perclose ProGlide™ SMC System if the packaging or sterile barrier has been previously opened or damaged or if the components appear to be damaged or defective.

    DO NOT RESTERILIZE OR REUSE. The Perclose ProGlide™ SMC System is intended for single use only.

    Do not use the Perclose ProGlide™ SMC System if the sterile field has been broken where bacterial contamination of the sheath or surrounding tissues may have occurred, since such a broken sterile field may result in infection.

    Do not use the Perclose ProGlide™ SMC System if the puncture site is located above the most inferior border of the inferior epigastric artery (IEA) and / or above the inguinal ligament based upon bony landmarks, since such a puncture site may result in a retroperitoneal hematoma. Perform a femoral angiogram to verify the location of the puncture site. Note: This may require both a right anterior oblique (RAO) and left anterior oblique (LAO) angiogram to adequately visualize where the sheath enters the femoral vessel.

    Do not use the Perclose ProGlide™ SMC System in arterial or venous access if the puncture is through the posterior wall or if there are multiple punctures in the same access site, since such punctures may result in a hematoma or retroperitoneal bleed.

    Do not use the Perclose ProGlide™ SMC System if the puncture site is located in the superficial femoral artery or the profunda femoris artery, or the bifurcation of these vessels, since such puncture sites may result in a pseudoaneurysm, intimal dissection, or an acute vessel closure (thrombosis of small artery lumen). Perform a femoral angiogram to verify the location of the puncture site. Note: This may require both a right anterior oblique (RAO) and left anterior oblique (LAO) angiogram to adequately visualize where the sheath enters the femoral vessel.

    Precautions :

    1. Prior to use, inspect the Perclose ProGlide™ SMC System to ensure that the sterile packaging has not been damaged during shipment. Examine all components prior to use to verify proper function. Exercise care during device handling to reduce the possibility of accidental device breakage.
    2. As with all catheter-based procedures, infection is a possibility. Observe sterile technique at all times when using the Perclose ProGlide™ SMC System. Employ appropriate groin management, as per hospital protocol, post procedure and post hospital discharge to prevent infection.
    3. Use a single wall puncture technique. Do not puncture the posterior wall of the vessel in arterial and venous access.
    4. Do not deploy the Perclose ProGlide™ Device at an elevated angle against resistance as this may cause a cuff miss or device breakage.
    5. There are no reaccess restrictions if previous arteriotomy / venotomy repairs were achieved with Abbott Medical SMC or SMCR systems.
    6. If significant blood flow is present around the Perclose ProGlide™ Device, do not deploy needles. Remove the device over a 0.038" (0.97 mm) (or smaller) guide wire and insert an appropriately sized sheath.
    7. Prior to depressing the plunger to advance the needles, stabilize the device by the body to ensure the foot is apposed to the vessel wall and the device does not twist during deployment. Twisting (torquing) of the device could lead to needle deflection resulting in a cuff miss. Do not use excessive force or repeatedly depress the plunger. Excessive force on the plunger during deployment could potentially cause breakage of the device, which may necessitate intervention and / or surgical removal of the device and vessel repair.
    8. Do not apply excessive force to the lever when opening the foot and returning the foot to its original position down to the body of the device. Do not attempt to remove the device without closing the lever. Excessive force on the lever or attempting to remove the device without closing the lever could cause breakage of the device and / or lead to vessel trauma, which may necessitate intervention and / or surgical removal of the device and vessel repair.
    9. Do not advance or withdraw the Perclose ProGlide™ Device against resistance until the cause of that resistance has been determined. Excessive force used to advance or torque the Perclose ProGlide™ Device should be avoided, as this may lead to significant vessel damage and / or breakage of the device, which may necessitate intervention and / or surgical removal of the device and vessel repair.
    10. If excessive resistance in advancing the Perclose ProGlide™ Device is encountered, withdraw the device over a 0.038" (0.97 mm) (or smaller) guide wire and reinsert the introducer sheath or use manual compression.
    11. Remove the Perclose ProGlide™ sheath before tightening the suture. Failure to remove the sheath prior to tightening the suture may result in detachment of the tip of the sheath.
    12. Care should be taken to avoid damage to the suture from handling. Avoid crushing damage due to application of surgical instruments such as clamps, forceps or needle holders.
    13. For catheterization procedures using a 5F – 8F procedural sheath, use manual compression in the event that bleeding from the femoral access site persists after the use of the Perclose ProGlide™ SMC System to obtain hemostasis.
    14. For catheterization procedures using a procedural sheath > 8F, use manual compression, compression assisted devices, surgical repair, and / or other appropriate treatment methods in the event that bleeding from the femoral access site persists after the use of the Perclose ProGlide™ SMC System to obtain hemostasis.
    15. For catheterization procedures using a procedural sheath > 8F, where the operating physician is not a vascular surgeon, it is recommended that a vascular surgeon or a surgeon with vascular training be available during the procedure to perform any necessary vascular surgical intervention.
    16. If the Perclose ProGlide™ Device is used to close and repair multiple access sites in the same vessel, space the access sites apart adequately to minimize sheath-device interference

    
    Potential Adverse Events :

    Potential adverse events associated with use of vessel closure devices may include, but are not limited to, the following:

    • Allergic reaction or hypersensitivity to device components
    • Vascular access complications which may require transfusion or vessel repair, including:
      • Anemia
      • Aneurysm
      • Arteriovenous fistula
      • Bleeding / hemorrhage / re-bleeding
      • Bruising
      • Hematoma
      • Embolism
      • Inflammation
      • Intimal tear / dissection
      • Perforation
      • Pseudoaneurysm
      • Retroperitoneal hematoma / bleeding
      • Scar formation
      • Wound dehiscence
      • Atrial arrhythmias
      • Ventricular arrhythmias
      • Arterial / venous stenosis
      • Arterial / venous occlusion
      • Arteriovenous fistula
      • Intimal tear / dissection
      • Ischemia distal to closure site
      • Nerve injury
      • Numbness
      • Thrombus formation
      • Vascular injury
      • Hypotension / hypertension
      • Vasovagal episode

      StarClose SE™ Vascular Closure System

      Indications for Use

      The StarClose SE™ Vascular Closure System is indicated for the percutaneous closure of common femoral artery access sites while reducing times to hemostasis, ambulation, and dischargeability in patients who have undergone diagnostic endovascular catheterization procedures utilizing a 5F or 6F procedural sheath.

      The StarClose SE™ Vascular Closure System is indicated for use to allow patients who have undergone diagnostic endovascular catheterization procedures to ambulate and be eligible for discharge as soon as possible after device placement.

      The StarClose SE™ Vascular Closure System is indicated for the percutaneous closure of common femoral artery access sites while reducing times to hemostasis and ambulation in patients who have undergone interventional endovascular catheterization procedures utilizing a 5F or 6F procedural sheath.

      Caution

      Federal law restricts this device to sale by or on the order of a physician (or allied healthcare professionals, authorized by, or under the direction of, such physicians) who is trained in diagnostic and therapeutic catheterization procedures and who has been trained by an authorized representative of Abbott Vascular.

      Prior to use, the operators must review the Instructions for Use and be familiar with the deployment techniques associated with the use of this device.

      Contraindications

      The StarClose SE™ Vascular Closure System is contraindicated for use in patients with known hypersensitivity to nickel-titanium.

      Warnings

      Do not use the StarClose SE™ Vascular Closure System if the packaging or sterile barrier has been previously opened or damaged or if the components appear to be damaged or defective.

      DO NOT RESTERILIZE OR REUSE. The StarClose SE™ Vascular Closure System and accessories are intended for single use only.

      Do not use the StarClose SE™ Vascular Closure System if the sterile field has been broken where bacterial contamination of the sheath or surrounding tissues may have occurred, since such a broken sterile field may result in infection.
      Do not use the StarClose SE™ Vascular Closure System if the puncture site is located above the most inferior border of the inferior epigastric artery (IEA) and / or above the inguinal ligament based upon bony landmarks, since such a puncture site may result in a retroperitoneal hematoma. Perform a femoral angiogram to verify the location of the puncture site.

      Do not use the StarClose SE™ Vascular Closure System if the puncture is through the posterior wall or if there are multiple punctures, since such punctures may result in a retroperitoneal hematoma.

      Do not use the StarClose SE™ Vascular Closure System if the puncture site is located in the superficial femoral artery or the profunda femoris artery, since such puncture sites may result in a pseudoaneurysm, intimal dissection, or an acute vessel closure (thrombosis of small artery lumen). Perform a femoral angiogram to verify the location of the puncture site.

      Precautions

      1. The StarClose SE™ Vascular Closure System should be used only by operators trained in diagnostic and interventional catheterization procedures who have been certified by an authorized representative of Abbott Vascular Inc.
      2. The StarClose SE™ Vascular Closure System is provided sterile and non-pyrogenic in unopened undamaged packaging. Products are sterilized with ethylene oxide and intended for single use only. Do not resterilize. Store in a cool, dry place.
      3. Prior to use, inspect the StarClose SE™ Vascular Closure System to ensure that the sterile packaging has not been damaged during shipment. Examine all components prior to use to verify proper function. Exercise care during device handling to reduce the possibility of accidental device breakage.
      4. As with all catheter-based procedures, infection is a possibility. Observe sterile technique at all times when using the StarClose SE™ Vascular Closure System. Employ appropriate groin management, as per hospital protocol, post-procedure and post-hospital discharge to prevent infection.
      5. Use a single wall puncture technique. Do not puncture the posterior wall of the artery.
      6. Do not use the StarClose SE™ Vascular Closure System to close vessels with diameters less than 5 mm.
      7. Do not deploy the Clip in areas of calcified plaque.
      8. The StarClose SE™ Vascular Closure System can be used ONLY with the StarClose Exchange System (included in the StarClose SE™ Vascular Closure System packaging).
      9. Do not advance or withdraw the StarClose SE™ Vascular Closure Device against resistance until the cause of that resistance has been determined. Excessive force used to advance or torque the StarClose SE™ device should be avoided, as this may lead to significant vessel damage and/or breakage of the device, which may necessitate interventional and/or surgical removal of the device and vessel repair.

      MRI Safety Information

      The StarClose Clip has been shown to be MR Conditional immediately following implantation. A patient with this implant can be scanned safely immediately after clip placement under the following conditions:

      • Static magnetic field of 3 Tesla or less
      • Spatial gradient magnetic field of 720 Gauss/cm or less
      • Maximum MR system reported whole-body-averaged specific absorption rate (SAR) of 3 W/kg for 15 minutes of scanning.

      In non-clinical testing, the StarClose Clip produced a temperature rise of 0.5°C at maximum MR system-reported whole-body-averaged specific absorption rate (SAR) of 3 W/kg for 15 minutes of MR scanning in a 3 Tesla MR system using a transmit/receive body coil.

      The MR image quality may be compromised if the area of interest is in the exact same area or relatively close to the position of the StarClose Clip. Therefore, optimization of MR imaging parameters to compensate for the presence of this implant may be necessary.

      Adverse Events

      Potential adverse events that could be associated with the use of this device include:

      • Major Vascular Complications (Composite)
        • Vascular Injury Requiring Repair
        • Surgery
        • Angioplasty
        • Ultrasound Guided Compression
        • Thrombin Injection or Other Percutaneous Procedure
        • Pseudoaneurysm
        • Arteriovenous Fistula
        • Hematoma (≥ 6 cm)
        • Late Access Site-related Bleeding
        • Transient Lower Extremity Ischemia
        • Ipsilateral Deep Vein Thrombosis
        • Transient Access Site-related Nerve Injury
        • Access Site-related Vessel Injury
        • Access Site Wound-related Dehiscence
        • Access Site-related Bleeding Requiring ≥ 30 minutes to Re-achieve Hemostasis
        • Localized Access Site Infection Treated with IM or Oral Antibiotics
        • UADE